News Par Views: After Listing At A Premium Of 20% Mankind Pharma's Management Explains Growth Plans | Anil Singhvi
Zee Business Video Team | Updated: May 11, 2023 07:01 AM IST
What is the business model and future plan of Mankind Pharma? Where will the money raised from IPO be used? Know from the company's Chairman, Ramesh Juneja and VC & MD Rajeev Juneja. Watch Anil Singhvi's exclusive conversation with Mankind Pharma's Chairman, Ramesh Juneja and VC & MD Rajeev Juneja after a strong listing at a premium of 20%.